Network analysis has pinpointed drug-like compounds, including 2-linoleolglycerol, tremulone, spiro [2.5] non-4-ene, 4-ethyl-8-methylene-5-trimethylsilyl, ethyl (9Z, 12Z, 15Z)-octadeca-9,12,15-trienoate, stigmasteryl methyl ether and tricylo [20.8.0.0 (7,16)] triacontane, 1(22),7(16)-diepoxy targeting key proteins involved in cancer progressions and tumorigenesis, such as AKT1, MDM STAT3, EGFR, CDK2, MTOR, MAPK3 PTGS2, MCL1 and TNF among others. This evidence concerns the gene MTOR and cancer.